| Grant number: | 12/14993-9 |
| Support Opportunities: | Research Grants - Young Investigators Grants |
| Start date: | July 01, 2013 |
| End date: | June 30, 2016 |
| Field of knowledge: | Biological Sciences - Physiology - Physiology of Organs and Systems |
| Principal Investigator: | Helena Cristina de Lima Barbosa |
| Grantee: | Helena Cristina de Lima Barbosa |
| Host Institution: | Instituto de Biologia (IB). Universidade Estadual de Campinas (UNICAMP). Campinas , SP, Brazil |
| City of the host institution: | Campinas |
| Associated researchers: | Antonio Carlos Boschiero ; Sandra Mara Ferreira |
| Associated scholarship(s): | 14/03547-3 - In vivo effect of reduced expression of ARHGAP21 on glucose homeostasis and expression of key proteins of glucose metabolism in pancreatic islet and peripheral tissues,
BP.IC 13/12827-7 - Type 3 muscarinic receptor activation and association with ADP-rybosilation factor 1 and 6 on the pancreatic beta-cell function: downstream signalling pathways, islet arquitecture and insulin secretion, BP.JP |
Abstract
Type 2 diabetes mellitus (T2D) is a heterogenic disorder characterised by chronic hyperglycemia, due to the combination of insulin resistance in peripheral tissues and a deficient insulin secretion in pancreatic islets. The cholinergic stimulation is one of the most important mechanisms that regulate the beta-cell function, in which M3 muscaric receptor activation results in an increase in the citoplasmic calcium concentration and an increment in nutrient-induced insulin secretion. There are evidences that M3 receptor interacts with small GTPases named ARFs in astrocitome, renal cells and neutrophills. Moreover, it is known that ARFs are involved in signalling pathways that regulates adherent junction turnover, through the distribution and traffic of the adhesion molecules complex components in epithelial cells, regulating cellular morphological changes. In addition, ARFs interact with ARHGAP21, a GTPase-activating protein that negatively controls insulin secretion in beta-cells. Then, for better understanding the beta-cell failure during the T2D progression, it is necessary to elucidate the M3 receptor downstream components, pancreatic beta-cell structure, communication and function, especially the glucose-induce insulin secretion. In addition, this knowledge will help to find new strategies to avoid and/or treat T2D. In this way, using MIN6 beta-cells and C57BL/6 mouse pancreatic islets, this project is aimed at elucidate: a) the molecular mechanisms involved in the ADP-rybosilation factor 1 and 6; b) its interaction with the GAP ARHGAP21 in the stimulation of the cholinergic muscarinic receptor M3 and; c) the regulation of cellular adhesion molecules ECAD on the pancreatic beta-cells functions. (AU)
| Articles published in Agência FAPESP Newsletter about the research grant: |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |